The market has performed strongly over the past year, with the S&P 500 continuing to reach new all-time highs. Despite this, several well-known names are down big from their 52-week highs. Fortunately, there is reason to believe they can stage significant recoveries. Below, we’ll break down three of these stocks in which Wall Street sees 30% or more upside. All data is as of the September 19 close unless otherwise indicated. Get Intuitive Surgical alerts:Analysts Eye Big Time Upside in Healthcare Stalwart I ...

Darden Restaurants, Inc. (NYSE:DRI) is one of the stocks on Jim Cramer’s radar. As the company is set to report its fiscal 2026 first-quarter earnings on September 18, Cramer commented: “Thursday morning, we get results from Darden, parent of Olive Garden and a bunch of other restaurant chains. I wish I could just say go buy it, but the restaurant group has suddenly gotten real out of favor. Let’s do this. If you want a piece of the Olive Garden, its principal property, buy small ahead of the quarter, may ...

Core Insights - Novo Nordisk's CEO Lars Fruergaard Jørgensen is stepping down, leading to a 3.9% drop in the company's stock price [1] - The company is seeking a successor, with Jørgensen's tenure resulting in tripled sales, profits, and share price over eight years [3] - Recent growth has slowed, with sales up less than 20% and profits only increasing by 14% in the last quarter, contributing to a significant decline in stock value over the past year [3] Company Developments - The board's decision to seek new leadership is attributed to recent market challenges and the decline in share price since mid-2024 [3] - The potential for a new CEO presents an opportunity for investors to purchase Novo Nordisk stock at a lower price, with the stock currently priced under 19 times earnings [4] - The company’s sales growth remains strong at nearly 20%, indicating potential for recovery under new leadership [4]